Portal hypertension associated with oxaliplatin administration: Clinical manifestations of hepatic sinusoidal injury

Clinical Colorectal Cancer

Volumn 8, Issue 4, 2009, Pages 225-230

  Slade, Julian H ^a   Alattar, Mona L ^a   Fogelman, David R ^a   Overman, Michael J ^a   Agarwal, Atin ^a   Maru, Dipen M ^a   Coulson, Ryanne L ^a   Charnsangavej, Chusilp ^a   Vauthey, J Nicolas ^a   Wolff, Robert A ^a   Kopetz, Scott ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Hepatotoxicity; Liver disease; Splenomegaly; Thrombocytopenia; Varices

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; AMLODIPINE PLUS BENAZEPRIL; BEVACIZUMAB; CAPECITABINE; EZETIMIBE PLUS SIMVASTATIN; FLUOROURACIL; FOLINIC ACID; HYDROXYZINE; IRON; METFORMIN; MONTELUKAST; MULTIVITAMIN; OCTREOTIDE; OLMESARTAN; OXALIPLATIN; PANTOPRAZOLE; PROPRANOLOL; SALBUTAMOL; THEOPHYLLINE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; ASCITES; ASTHMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CECUM TUMOR; CLINICAL ARTICLE; CLINICAL FEATURE; COLON BIOPSY; COLONOSCOPY; COLORECTAL CANCER; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; HEMORRHOID; HEMORRHOID HEMORRHAGE; HUMAN; HUMAN TISSUE; HYPERTENSION; LIVER INJURY; LIVER METASTASIS; LIVER SINUSOID; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PORTAL PHLEBOGRAPHY; RECTUM CARCINOMA; SPLENOMEGALY; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; TREATMENT OUTCOME;

EID: 70350168942     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2009.n.038     Document Type: Article

References (28)

1. André T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350:2343-2351
2. Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007; 25:2198-2204
3. de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18:29382947.
4. Cassidy J, Tabernero J, Twelves C, et al. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. J Clin Oncol 2004; 22:2084-2091
5. Alberts SR, Horvath WL, Sternfeld WC, et al. Oxaliplatin, flurouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group phase II study. J Clin Oncol 2005; 23:9243-9249
6. Vauthey JN, Abdalla EK. Unresectable hepatic colorectal metastases: need for new surgical strategies. Ann Surg Oncol 2006; 13:5-6.
7. Kopetz S, Vauthey JN. Perioperative chemotherapy for respectable hepatic metastases. Lancet 2008; 371:963-965
8. Nordlinger B, Sørbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for respectable liver metastases from colorectal cancer (EORTC Intergroup Trial 40983): a randomised controlled trial. Lancet 2008; 371:1007-1016
9. Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004; 15:460-466
10. Nakano H, Oussoultzoglou E, Rosso E, et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008; 247:118-124
11. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24:2065-2072
12. Aloia T, Sebagh M, Plasse M, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006; 24:4983-4990
13. Hewes JC, Dighe S, Morris RW, et al. Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J Surg 2007; 31:353-364
14. Schouten van der Velden AP, Punt CJ, Van Krieken JH, et al. Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month. Eur J Surg Oncol 2008; 34:353-355
15. Ishizaki T, Abe T, Koyanagi Y, et al. A case of liver failure associated with liver damage due to mFOLFOX6 after resection for multiple liver metastases from colorectal cancer. Gan To Kagaku Ryoho 2007; 34:945-948
16. Arotçarena R, Calès V, Berthelémy P, et al. Severe sinusoidal lesions: a serious and overlooked complication of oxaliplatin-containing chemotherapy? Gastroenterol Clin Biol 2006; 30:1313-1316
17. Tisman G, MacDonald D, Shindell N, et al. Oxaliplatin toxicity masquerading as recurrent colon cancer. J Clin Oncol 2004; 22:3202-3204
18. Politano S, Pathak P, Hoff PM, et al. The use of 5-fluorouracil and oxaliplatin (FOLFOX) for colorectal cancer is associated with the development of splenomegaly and thrombocytopenia. Presented at: The American Society of Clinical Oncology Annual Meeting; May 30-June 3, 2008; Chicago, Illinois. Abstract 4102.
19. Kauffman CR, Mahvash A, Kopetz S, et al. Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy. Cancer 2008; 112:2283-2288
20. Pavic M, Moncharmont P, Sève P, et al. Oxaliplatin-induced immune thrombocytopenia. Gastroenterol Clin Biol 2006; 30:797-798
21. Curtis BR, Kaliszewski J, Marques MB, et al. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin. Am J Hematol 2006; 81:193-198
22. Taleghani BM, Meyer O, Fontana S, et al. Oxaliplatin-induced immune pancytopenia. Transfusion 2005; 45:704-708
23. Koutras AK, Makatsoris T, Paliogianni F, et al. Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis. Oncology 2004; 67:179-182
24. Dold FG, Mitchell EP. Sudden-onset thrombocytopenia with oxaliplatin. Ann Intern Med 2003; 139:E156.
25. Sørbye H, Bruserud Y, Dahl O. Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis. Acta Oncol 2001; 40:882-883
26. DeLeve LD, Ito Y, Bethea NW, et al. Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstructive syndrome. Am J Physiol Gastrointest Liver Physiol 2003; 284:G1045-52.
27. Deleve LD, Wang X, Kuhlenkamp JF, et al. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 1996; 23:589-599
28. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstructive syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22:27-42.